Skip to main content
Have a personal or library account? Click to login
Synthesis of some benzimidazole derivatives endowed with 1,2,3-triazole as potential inhibitors of hepatitis C virus Cover

Synthesis of some benzimidazole derivatives endowed with 1,2,3-triazole as potential inhibitors of hepatitis C virus

Acta Pharmaceutica
Volume 66 (2016): Issue 2 (June 2016)
By: ,  ,  ,  ,   and    
Open Access
|May 2016
References

References

  1. 1. J. S. Au and P. J. Pockros, Novel therapeutic approaches for hepatitis C,.(2014) 78–88; DOI: 10.1038/clpt.2013.206.
    Open DOISearch in Google Scholar
  2. 2. M. P. Manns, J. G. McHutchison, S. C. Gordon, V. K. Rustgi, M. Shiffman, R. Reindollar, Z. D. Goodman, K. Koury, M. Ling and J. K. Albrecht, Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial,(2001) 958–965.
    Open DOISearch in Google Scholar
  3. 3. M. W. Fried, M. L. Shiffman, K. R. Reddy, C. Smith, G. Marinos, F. L. Gonçales Jr., D. Häussinger, M. Diago, G. Carosi, D. Dhumeaux, A. Craxi, A. Lin, J. Hoffman and J. Yu, Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection,(2002) 975–982; DOI: 10.1056/NEJMoa020047.
    Open DOISearch in Google Scholar
  4. 4. Y. Bansal and O. Silakari, The therapeutic journey of benzimidazoles: A review,(2012) 6208–6236; DOI: 10.1016/j.bmc.2012.09.013.
    Open DOISearch in Google Scholar
  5. 5. V. Boido, G. Paglietti, M. Tonelli and G. Vitale,, in(Ed. A. Carta), Research Signpost, Kerala 2009, pp. 41–93.
    Search in Google Scholar
  6. 6. B. A. Katz, J. Clark, J. Finer-Moore, T. Jenkins, C. Johnson, M. Ross, C. Luong, W. Moore and R. Stroud, Design of potent selective zinc-mediated serine protease inhibitors,(1998) 608–612; DOI: 10.1038/35422.
    Open DOISearch in Google Scholar
  7. 7. D. Sperandio, A. R. Gangloff, J. Litvak, R. Goldsmith, J. M. Hataye, V. R. Wang, E. J. Shelton, K. Elrod, J. W. Janc, J. M. Clark, K. Rice, S. Weinheimer, K. Yeung, N. A. Meanwell, D. Hernandez, A. J. Staab, B. L. Venables and J. R. Spencer, Highly potent non-peptidic inhibitors of the HCV NS3/NS4A serine protease,(2002) 3129–3133; DOI: 10.1016/S0960-894X(02)00680-7.
    Open DOISearch in Google Scholar
  8. 8. H. I. El Diwani, H. T. Abdel-Mohsen, I. Salama, F. A.-F. Ragab, M. M. Ramla, S. A. Galal, M. M. Abdalla, A. Abdel-Wahab and M. A. El Demellawy, Synthesis, molecular modeling, and biological evaluation of novel benzimidazole derivatives as inhibitors of hepatitis C virus RNA replication,(2014) 856–866; DOI: 10.1248/cpb.c13-01009.
    Open DOISearch in Google Scholar
  9. 9. L. Garuti, M. Roberti and G. Gentilomi, Synthesis and antiviral assays of some 2-substituted benzimidazole-N-carbamates,(2000) 35–39; DOI: 10.1016/S0014-827X(99)00117-2.
    Open DOISearch in Google Scholar
  10. 10. S. Budow, M. Kozlowska, A. Gorska, Z. Kazimierczuk, H. Eickmeier, P. La Colla, G. Gosselin and F. Seela, Substituted benzimidazole: antivral activity and synthesis of nucleosides,(2009) 225–250; DOI: 10.3998/ark.5550190.0010.319.
    Open DOISearch in Google Scholar
  11. 11. M. F. Tonelli, F. Novelli, B. Tasso, I. Vazzana, A. Sparatore, V. Boido, F. Sparatore, P. La Colla, G. Sanna, G. Giliberti, B. Busonera, P. Farci, C. Ibba and R. Loddo, Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents,(2014) 4893–4909; DOI: 10.1016/j.bmc.2014.06.043.
    Open DOISearch in Google Scholar
  12. 12. Y. Saito, V. Escuret, D. Durantel, F. Zoulim, R. F. Schinazic and L. A. Agrofoglio, Synthesis of 1,2,3-triazolo-carbanucleoside analogues of ribavirin targeting an HCV in replicon,(2003) 3633–3639; DOI: 10.1016/S0968-0896(03)00349-3.
    Open DOISearch in Google Scholar
  13. 13. F. D. Da Silva, M. C. B. V. de Souza, I. I. P. Frugulhetti, H. C. Castro, S. L. D Souza, T. M. L. de Souza, D. Q. Rodrigues, A. M. T. Souza, P. A. Abreu, F. Passamani, C. R. Rodrigues and V. F. Ferreira, Synthesis, HIV-RT inhibitory activity and SAR of 1-benzyl-1-1,2,3-triazole derivatives of carbohydrates,(2009) 373–383; DOI: 10.1016/j.ejmech.2008.02.047.
    Open DOISearch in Google Scholar
  14. 14. D. K. Mohapatra, P. K. Maity, M. Shabab and M. I. Khan, Click chemistry based rapid one-pot synthesis and evaluation for protease inhibition of new tetracyclic triazole fused benzodiazepine derivatives,(2009) 5241–5245; DOI: 10.1016/j.bmcl.2009.06.107.
    Open DOISearch in Google Scholar
  15. 15. T. O. Olomola, R. Klein, K. A. Lobb, Y. Sayed and P. T. Kaye, Synthesis and evaluation of coumarin derivatives as potential dual-action HIV-1 protease and reverse transcriptase inhibitors,(2013) 1964–1971; DOI: 10.1016/j.bmc.2013.01.025.
    Open DOISearch in Google Scholar
  16. 16. M. M. Heravi, A. Keivanloo, M. Rahimizadeh, M. Bakavoli and M. Ghassemzadeh, Pd–Cu catalyzed heterocyclization during Sonogashira coupling: synthesis of 3-benzylthiazolo[3,2-]benzimidazole,(2004) 5747–5749; DOI: 10.1016/j.tetlet.2004.05.094.
    Open DOISearch in Google Scholar
  17. 17. K.-C. Tiew, D. Dou, T. Teramoto, H. Lai, K. R. Alliston, G. H. Lushington, R. Padmanabhan and W. C. Groutas, Inhibition of Dengue virus and West Nile virus proteases by click chemistry-derived benz[] isothiazol-3(2)-one derivatives,(2012) 1213–1221; DOI: 10.1016/j.bmc.2011.12.047.
    Open DOISearch in Google Scholar
  18. 18. C. Baba, K. Yanagida, T. Kanzaki and M. Baba, Colorimetric lactate dehydrogenase (LDH) assay for evaluation of antiviral activity against bovine viral diarrhoea virus (BVDV)(2005) 33–39; DOI: 10.1016/j.biomaterials.2014.01.054.
    Open DOISearch in Google Scholar
  19. 19. K. Sako, H. Aoyama, S. Sato, Y. Hashimoto and M. Baba,-carboline derivatives with anti-bovine viral diarrhea virus (BVDV) activity,(2008) 3780–3790; DOI: 10.1016/j.bmc.2008.01.052.
    Open DOISearch in Google Scholar
  20. 20. H. C. Kolb, M. G. Finn and K. B. Sharpless, Click chemistry: Diverse chemical function from a few good reactions,(2001) 2004–2021; DOI: 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5.
    Open DOISearch in Google Scholar
  21. 21. J. E. Moses and A. D. Moorhouse, The growing applications of click chemistry,(2007) 1249–1262; DOI: 10.1039/b613014n.
    Open DOISearch in Google Scholar
  22. 22. S. G. Agalave, S. R. Maujan and V. S. Pore, Click chemistry: 1,2,3-Triazoles as pharmacophores,(2011) 2696–2718; DOI: 10.1002/asia.201100432.
    Open DOISearch in Google Scholar
  23. 23. J.-F. Lutz and Z. Zarafshani, Efficient construction of therapeutics, bioconjugates, biomaterials and bioactive surfaces using azide-alkyne “click” chemistry,(2008) 958–970; DOI: 10.1016/j.addr.2008.02.004.
    Open DOISearch in Google Scholar
  24. 24. K. Lin, R. B. Perni, A. D. Kwong and c. Lin, VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells,(2006) 1813–1822; DOI: 10.1128/AAC.50.5.1813-1822.2006.
    Open DOISearch in Google Scholar
  25. 25. J. G. Topliss, Utilization of operational schemes for analog synthesis in drug design,(1972) 1006–1011; DOI: 10.1021/jm00280a002.
    Open DOISearch in Google Scholar
  26. 26. J. G. Topliss, A manual method for applying the Hansch approach to drug design,(1977) 463–469; DOI: 10.1021/jm00214a001.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/acph-2016-0014 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 219 - 231
Accepted on: Oct 27, 2015
Published on: May 28, 2016
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
benzimidazole,
triazole,
anilide,
antiviral,
HCV,
HBV
Related subjects:
Pharmacy,
Pharmacy, other

© 2016 Bahaa G. M. Youssif, Yaseen A. M. Mohamed, Mohammed T. A. Salim, Fuyuhiko Inagaki, Chisato Mukai, Hajjaj H. M. Abdu-Allah, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 66 (2016): Issue 2 (June 2016)
Previous article
Next article